BackLAUNXP Biomedical , Ltd Overview

LAUNXP Biomedical , Ltd Current Cash

Latest current cash for 6876.TWO: $360M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$355.28M
↑ 44.37% YoYΔ $109.19M vs prior year quarter

Peer trimmed avg / median

Loading

LAUNXP Biomedical , Ltd Current Cash History

Loading

LAUNXP Biomedical , Ltd vs. peers: Current Cash Comparison

Loading

LAUNXP Biomedical , Ltd Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LAUNXP Biomedical , Ltd (6876.TWO) FAQ

As of the most recent data (June 2026), 6876.TWO shows a current cash of $360M. That compares with $250M in the prior-year period — up 44.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6876.TWO's current cash is now $360M (was $250M) — a 44.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether LAUNXP Biomedical , Ltd is outperforming or lagging.

Tracking 6876.TWO's current cash over time shows whether LAUNXP Biomedical , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $360M That compares with $250M in the prior-year period — up 44.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has LAUNXP Biomedical , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $360M) with ownership activity and broader fundamentals.

LAUNXP Biomedical , Ltd's current cash is $360M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.